Aqueous gels formulated using hydrophilic polymers (hydrogels) along with those based on
stimuli responsive polymers (in situ gelling or gel forming systems) continue to attract …

The eye is a highly specialized organ that is subject to a huge range of pathology. Both local
and systemic disease may affect different anatomical regions of the eye. The least invasive …

The eye, an intricate organ comprising physical and physiological barriers, poses a
significant challenge for ophthalmic physicians seeking to treat serious ocular diseases …

The topical route is the most preferred one for administering drugs to eyes, skin and wounds
for reaching enhanced efficacy and to improve patient compliance. Topical administration of …

Slow-release delivery systems are needed to ensure long-term sustained treatments for
retinal diseases such as age-related macular degeneration and diabetic retinopathy, which …

Age‐related macular degeneration (AMD) and glaucoma are global ocular diseases with
high blindness rate. RNA interference (RNAi) is being increasingly used in the treatment of …

The eye is a challenging organ for ophthalmic drug delivery due to the barriers associated
with the anterior and posterior segments like nasolacrimal drainage, blinking, induced …

Controlled/sustained delivery systems have been developed rapidly which show the ability
to overcome the obstacles of traditional delivery systems. Daily development of biomedical …

Abstract A novel Liposome Aggregate Platform (LAP) system for prolonged retention of
drugs in the posterior eye segment after intravitreal injection (IVT) was developed and …

Diseases of the posterior eye segment are often characterized by intraocular inflammation,
which causes, in the long term, severe impairment of eye functions and, ultimately, vision …